Selected article for: "cardiovascular disease and chronic liver disease"
Author: John P. A. Ioannidis; Cathrine Axfors; Despina G. Contopoulos-Ioannidis
Title: Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters
  • Document date: 2020_4_8
    • ID: 2cwvga0k_21
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.05.20054361 doi: medRxiv preprint conditions for worse outcome in COVID-19 may include 7-9 cardiovascular disease, hypertension, diabetes, chronic obstructive pulmonary disease and severe asthma, kidney failure, severe liver disease, immunodeficiency, and malignancy. We followed the data collection principles of each national and state or.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.05.20054361 doi: medRxiv preprint conditions for worse outcome in COVID-19 may include 7-9 cardiovascular disease, hypertension, diabetes, chronic obstructive pulmonary disease and severe asthma, kidney failure, severe liver disease, immunodeficiency, and malignancy. We followed the data collection principles of each national and state organization on how underlying conditions were defined. Data were readily available in published reports for New York City and we obtained additional such data according to the presence or not of underlying conditions from the Italian COVID-19 team (personal communication, Dr. Luigi Palmieri) as of April 2, 2020 and from the Dutch COVID-19 team (personal communication, Susan van den Hof) as of April 4, 2020. We encourage other organizations to send us similar data, as they become available, so that they can be incorporated in further updates. Proportions were synthesized in a random effects meta-analysis with evaluation of between-dataset heterogeneity by the I 2 and Q statistics.

    Search related documents:
    Co phrase search for related documents
    • cardiovascular disease and kidney failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and malignancy immunodeficiency: 1, 2
    • cardiovascular disease and malignancy immunodeficiency severe liver disease: 1
    • cardiovascular disease and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic severe asthma obstructive pulmonary disease and kidney failure: 1
    • chronic severe asthma obstructive pulmonary disease and liver disease: 1, 2
    • chronic severe asthma obstructive pulmonary disease and malignancy immunodeficiency: 1
    • chronic severe asthma obstructive pulmonary disease and malignancy immunodeficiency severe liver disease: 1
    • chronic severe asthma obstructive pulmonary disease and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • kidney failure and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • kidney failure and malignancy immunodeficiency: 1
    • kidney failure and malignancy immunodeficiency severe liver disease: 1
    • kidney failure and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • liver disease and malignancy immunodeficiency: 1
    • liver disease and malignancy immunodeficiency severe liver disease: 1
    • liver disease and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • malignancy immunodeficiency and obstructive pulmonary disease: 1, 2
    • malignancy immunodeficiency severe liver disease and obstructive pulmonary disease: 1